Fingerprint
Dive into the research topics of 'Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically